Scarica l'app Stockscreener
90.19
0.69%
0.62
Precedente Chiudi:
$89.57
Aprire:
$89.63
Volume 24 ore:
503.89K
Relative Volume:
0.95
Capitalizzazione di mercato:
$5.22B
Reddito:
$76.81M
Utile/perdita netta:
$-162.42M
Rapporto P/E:
-30.16
EPS:
-2.99
Flusso di cassa netto:
$-122.49M
1 W Prestazione:
+0.23%
1M Prestazione:
+5.34%
6M Prestazione:
+37.61%
1 anno Prestazione:
+3.41%
Intervallo 1D:
$89.22
$91.78
Intervallo di 1 settimana:
$87.85
$93.24
Portata 52W:
$47.86
$96.39
Arcellx Inc Stock (ACLX) Company Profile
Nome
Arcellx Inc
Settore
Industria
Telefono
240-327-0603
Indirizzo
800 BRIDGE PARKWAY, REDWOOD CITY
Confronta ACLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACLX
Arcellx Inc
|
90.19 | 5.18B | 76.81M | -162.42M | -122.49M | -2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Iniziato | Wolfe Research | Peer Perform |
| 2025-10-16 | Iniziato | Stifel | Buy |
| 2025-06-17 | Iniziato | Citigroup | Buy |
| 2024-10-08 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-31 | Iniziato | Piper Sandler | Overweight |
| 2024-03-07 | Iniziato | Morgan Stanley | Overweight |
| 2024-01-04 | Reiterato | Needham | Buy |
| 2023-12-19 | Iniziato | Scotiabank | Sector Outperform |
| 2023-10-30 | Iniziato | TD Cowen | Outperform |
| 2023-10-17 | Iniziato | UBS | Buy |
| 2023-05-18 | Iniziato | Truist | Buy |
| 2023-04-14 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-14 | Iniziato | Stifel | Buy |
| 2023-02-13 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-13 | Ripresa | BofA Securities | Buy |
| 2022-10-31 | Iniziato | Guggenheim | Buy |
| 2022-10-27 | Iniziato | Needham | Buy |
| 2022-07-20 | Iniziato | Canaccord Genuity | Buy |
| 2022-03-01 | Iniziato | BofA Securities | Buy |
| 2022-03-01 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Arcellx Inc Borsa (ACLX) Ultime notizie
Can Arcellx Inc. stock withstand economic slowdownEarnings Beat & Proven Capital Preservation Methods - newser.com
Arcellx Inc’s Strategic Advantage in Gilead Partnership Drives Buy Rating and $130 Price Target - TipRanks
Risk vs reward if holding onto Arcellx Inc.Weekly Risk Report & Entry Point Confirmation Signals - newser.com
What institutional flow reveals about Arcellx Inc.Watch List & Fast Entry Momentum Alerts - newser.com
Tools to assess Arcellx Inc.’s risk profileWeekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com
How Arcellx Inc. stock performs during Fed tightening cyclesPrice Action & AI Forecasted Entry/Exit Points - newser.com
Is Arcellx Inc. stock a dividend growth opportunityQuarterly Trade Report & AI Driven Stock Movement Reports - newser.com
Why Arcellx Inc. is moving today2025 Price Targets & Daily Market Momentum Tracking - newser.com
Wolfe Research Initiates Coverage of Arcellx (ACLX) with Peer Perform Recommendation - Nasdaq
Arcellx (NASDAQ: ACLX) plans ASH event on Phase 2 iMMagine-1 myeloma trial data - Stock Titan
Arcellx CMO Heery sells $30,600 in ACLX stock By Investing.com - Investing.com South Africa
Arcellx CMO Heery sells $30,600 in ACLX stock - Investing.com
Arcellx stock initiated at Peerperform by Wolfe Research amid BCMA market competition - Investing.com Nigeria
Arcellx initiated with a Peer Perform at Wolfe Research - TipRanks
Can technical indicators confirm Arcellx Inc.’s reversalGlobal Markets & High Return Stock Watch Alerts - newser.com
Will Arcellx Inc. stock split again soonJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
Trend analysis for Arcellx Inc. this weekSwing Trade & Community Trade Idea Sharing - newser.com
Price-Driven Insight from (ACLX) for Rule-Based Strategy - news.stocktradersdaily.com
Using Python tools to backtest Arcellx Inc. strategiesWatch List & Stepwise Entry and Exit Trade Signals - newser.com
Arcellx Inc.: Promising Developments and Strategic Positioning Drive Buy Rating - TipRanks
Arcellx, Inc. Reports Increased Loss Amid Rising Expenses - TipRanks
Arcellx Inc Azioni (ACLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):